James Arthur Bristol, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 24,200 shares at $40.50 ($966K) on 2019-08-13, disclosed to the SEC on 2019-08-13.
Open-market sale of $966k DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.24 | 11,513 | $452K | 46.8% |
| 2 | $40.50 | 12,687 | $514K | 53.2% |
| Total | $39.90 avg | 24,200 | $966K | 100% |
| Filing → |
| DCPH | SELL | 2021-04-14 | $1.3M | — | Filing → |
| DCPH | SELL | 2021-01-20 | $352K | — | Filing → |
| DCPH | SELL | 2020-10-13 | $2.5M | — | Filing → |